Visualitza per autor "Rodríguez Pizà, Ignasi"

Ordena per: Ordre: Resultats:

  • Rodríguez Pizà, Ignasi; Raya Chamorro, Ángel; Navarro, Susana; Izpisúa Belmonte, J. C.; Bueren, Juan; Consiglio, Antonella; Sánchez Danés, Adriana, 1984-; Guenechea, Guillermo; Richaud Patin, Yvonne (Nature Publishing Group, 2010)
    The generation of patient-specific induced pluripotent stem cells (iPSCPSCPSCs) offers unprecedented opportunities for modeling and treating human disease. In combination with gene therapy, the iPSCPSCPSC technology can ...
  • Rodríguez Pizà, Ignasi; Raya Chamorro, Ángel; Aran, Begoña; Veiga, Anna; Izpisúa Belmonte, J. C.; Barri, Pere N.; Muñoz, Yolanda; Consiglio, Antonella (Springer, 2010)
    We report here the legislative issues related to/nembryo research and human embryonic stem cell (hESC)/nresearch in Spain and the derivation of nine hESC lines at/nthe Center of Regenerative Medicine in Barcelona. You ...
  • Rodríguez Pizà, Ignasi (Universitat Pompeu Fabra, 2010-07-05)
    Les cèl·lules mare embrionàries humanes (hESC) i més recentment les cèl·lules de pluripotència induïda (iPSC) representen una oportunitat sense precedents per al desenvolupament de noves estratègies terapèutiques per ...
  • Rodríguez Pizà, Ignasi; Verma, Inder M.; Veiga, Anna; Aasen, Trond; Izpisúa Belmonte, J. C.; Bueren, Juan; Garreta, Elena; Tiscornia, Gustavo; Sleep Ronquillo, Eduard; Raya Chamorro, Ángel; Río, Paula; Consiglio, Antonella; Barrero Núñez, María José; Navarro, Susana; Vassena, Rita; Guenechea, Guillermo (Nature Publishing Group, 2009)
    The generation of induced pluripotent stem (iPS) cells has enabled the derivation of patient-specific pluripotent cells and/nprovided valuable experimental platforms to model human disease. Patient-specific iPS cells are ...
  • Raya Chamorro, Ángel; Rodríguez Pizà, Ignasi; Aran, Begoña; Consiglio, Antonella; Barri, Pere N.; Veiga, Anna; Izpisúa Belmonte, J. C. (Cold Spring Harbor Laboratory Press-CSHL Press, 2008)
    Human embryonic stem (hES) cells represent a potential source for cell replacement therapy of many degenerative diseases. Most frequently, hES cell lines are derived from surplus embryos from assisted reproduction cycles, ...
  • Rodríguez Pizà, Ignasi; Giorgetti, Alessandra; Izpisúa Belmonte, J. C.; Veiga, Anna; Azqueta, Carmen; Montserrat, Nuria (Nature Publishing Group, 2010)
    Induced pluripotent stem cells (iPSC ) provide an invaluable resource for regenerative medicine as they allow the generation/nof patient-specific progenitors with potential value for cell therapy. However, in many instances, ...
  • Rodríguez Pizà, Ignasi; Barragan, Montserrat; González, Federico; Izpisúa Belmonte, J. C.; Batlle Morera, Laura; Vassena, Rita; Montserrat, Nuria; Tiscornia, Gustavo (National Academy of Sciences, 2009)
    Induced pluripotent stem (iPS) cells have generated keen interest/ndue to their potential use in regenerative medicine. They have/nbeen obtained from various cell types of both mice and humans by/nexogenous delivery of ...
  • Rodríguez Pizà, Ignasi; Vassena, Rita; Richaud Patin, Yvonne; Izpisúa Belmonte, J. C.; Raya Chamorro, Ángel; Veiga, Anna; Barrero Núñez, María José; González, Federico (AlphaMed Press and Wiley-Blackwell, 2010)
    The availability of induced pluripotent stem cells (iPSCs)/nhas created extraordinary opportunities for modeling and/nperhaps treating human disease. However, all reprogramming/nprotocols used to date involve the use of ...